Rhinomed Limited
RHNMF · OTC
12/30/2023 | 6/30/2023 | 12/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $7,926 | $18,517 | $30,885 | $31,389 |
| - Cash | $0 | $1,989 | $3,631 | $1,985 |
| + Debt | $0 | $337 | $4,740 | $337 |
| Enterprise Value | $7,926 | $16,864 | $31,994 | $29,741 |
| Revenue | $8,000 | $4,089 | $3,384 | $5,659 |
| % Growth | 95.7% | 20.8% | -40.2% | – |
| Gross Profit | $8,000 | $360 | -$551 | $4,096 |
| % Margin | 100% | 8.8% | -16.3% | 72.4% |
| EBITDA | $8,000 | -$4,441 | -$4,207 | -$2,279 |
| % Margin | 100% | -108.6% | -124.3% | -40.3% |
| Net Income | $0 | -$6,254 | -$4,654 | -$2,031 |
| % Margin | 0% | -153% | -137.6% | -35.9% |
| EPS Diluted | 0 | -0.022 | -0.016 | -0.008 |
| % Growth | 100% | -34.4% | -114.5% | – |
| Operating Cash Flow | -$7,202 | -$4,459 | -$2,719 | -$3,587 |
| Capital Expenditures | $0 | -$56 | -$39 | -$640 |
| Free Cash Flow | -$7,202 | -$4,514 | -$2,759 | -$4,227 |